Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA ...

A group of AIDS activists obtained an R&D pact at the heart of a settlement between the U.S. government and Gilead Sciences ...

This is the year artificial intelligence has emerged in the public square as a full-fledged bogeyman. So this month’s low-key ...

UnitedHealth touts a new home care audit, and more health insurers sue CMS over Medicare Advantage quality ratings.

U.S. health secretary Robert F. Kennedy Jr. is pressing forward with his effort to help Americans stop taking SSRI ...

A dementia prevention trial praised as a "landmark" effort further demonstrated the promise of structured programs tailored ...

The U.S. can save lives from excess alcohol use without taking drastic measures. Here are 12 steps that can help.

The results of a recent AI competition show that better data trumps bigger models when it comes to predicting properties of ...

America's hidden alcohol epidemic — the toll, emerging risks, shifting usage, and economic stakes — broken down in 10 charts.

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. LONDON — An experimental Alzheimer’s ...

In a private meeting, HHS officials met with mental health professionals to work on guidance for stopping SSRIs.

Four years into the U.S. Food and Drug Administration’s review of Zyn nicotine pouches, and not long before the agency approved them for sale, an FDA toxicologist ran some informal tests in her ...